Literature DB >> 21339319

Cardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: how to choose.

Hugh Tunstall-Pedoe.   

Abstract

Mesh：

Year:  2011        PMID： 21339319     DOI： 10.1136/hrt.2010.214858

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  14 in total

1.  Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study.

Authors:  Justin M Bachmann; Benjamin L Willis; Colby R Ayers; Amit Khera; Jarett D Berry
Journal:  Circulation       Date:  2012-05-23       Impact factor: 29.690

2.  Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative.

Authors:  Sheldon W Tobe; James A Stone; Melissa Brouwers; Onil Bhattacharyya; Kimberly M Walker; Martin Dawes; Jacques Genest; Steven Grover; Gordon Gubitz; David Lau; Andrew Pipe; Peter Selby; Mark S Tremblay; Darren E R Warburton; Richard Ward; Vincent Woo; Lawrence A Leiter; Peter P Liu
Journal:  CMAJ       Date:  2011-09-12       Impact factor: 8.262

3.  Cardiovascular risk prediction models with myocardial perfusion imaging in chronic kidney disease: ACCESSing digits or focusing on the patient?

Authors:  Dimitri Patriki; Andreas A Giannopoulos
Journal:  J Nucl Cardiol       Date:  2018-07-16       Impact factor: 5.952

4.  Assessing, communicating, and managing risk in general practice.

Authors:  Lyndal Trevena
Journal:  Br J Gen Pract       Date:  2014-04       Impact factor: 5.386

Review 5.  New risk markers for cardiovascular prevention.

Authors:  Guy G De Backer
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

6.  Cardiovascular prevention: Frontiers in lipid guidelines.

Authors:  Eun Ji Kim; Anthony S Wierzbicki
Journal:  Clin Med (Lond)       Date:  2020-01       Impact factor: 2.659

7.  Adding value to myocardial perfusion scintigraphy: A prediction tool to predict adverse cardiac outcomes and risk stratify.

Authors:  Ricardo A Nieves; Syed Bukhari; Matthew E Harinstein
Journal:  J Nucl Cardiol       Date:  2021-06-24       Impact factor: 5.952

Review 8.  The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective.

Authors:  Naomi J Rankin; David Preiss; Paul Welsh; Karl E V Burgess; Scott M Nelson; Debbie A Lawlor; Naveed Sattar
Journal:  Atherosclerosis       Date:  2014-09-30       Impact factor: 5.162

Review 9.  Assessment and relevance of carotid intima-media thickness (C-IMT) in primary and secondary cardiovascular prevention.

Authors:  Alessio Ravani; Jose Pablo Werba; Beatrice Frigerio; Daniela Sansaro; Mauro Amato; Elena Tremoli; Damiano Baldassarre
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

10.  A cardiovascular disease policy model: part 2-preparing for economic evaluation and to assess health inequalities.

Authors:  K D Lawson; J D Lewsey; I Ford; K Fox; L D Ritchie; H Tunstall-Pedoe; G C M Watt; M Woodward; S Kent; M Neilson; A H Briggs
Journal:  Open Heart       Date:  2016-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.